EMEA-001636-PIP01-14-M03
Key facts
| Invented name |
Verquvo
|
| Active substance |
Vericiguat
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0454/2022
|
| PIP number |
EMEA-001636-PIP01-14-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of left ventricular failure
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Bayer AG
Email: pediatrics.medical-affairs-europe@bayer.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|